Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Divi’s Laboratories Ltd.

Divi’s Lab

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Large-cap - With a market cap of ₹1752.27 Cr.

EX-Date	Purpose
29 05 2021	Final Dividend & Audited Results
07 08 2021	Quarterly Results
06 11 2021	Quarterly Results
04 02 2022	Quarterly Results
11 02 2022	Quarterly Results (Revised)
23 05 2022	Dividend & Audited Results
12 08 2022	Quarterly Results
07 11 2022	Quarterly Results
03 02 2023	Quarterly Results
20 05 2023	Final Dividend & Audited Results
14 08 2023	Quarterly Results
06 11 2023	Quarterly Results
10 02 2024	Quarterly Results
09 11 2024	Quarterly Results
03 02 2025	Quarterly Results
17 05 2025	Dividend & Audited Results

News

02-JAN-2025

Divi’s Laboratories starts commercial operations of Unit III greenfield project at Andhra Pradesh

The company has commenced commercial operations from a part of the Phase I of Unit III greenfield project from January 01, 2025

03:58 PM

03-FEB-2023

Divi’s Laboratories reports 66% fall in Q3 consolidated net profit

Total consolidated income of the company decreased by 27.41% to Rs 1821.93 crore for Q3FY23

03:19 PM

06-NOV-2023

Divi’s Laboratories reports 29% fall in Q2 consolidated net profit

Total consolidated income of the company increased by 3.10% at Rs 1995 crore for Q2FY24

02:30 PM

08-NOV-2022

Divi’s Laboratories reports 19% fall in Q2 consolidated net profit

Total consolidated income of the company marginally fall by 3.59% at Rs 1934.62 crore for Q2FY23

11:59 AM

11-NOV-2024

Divi’s Laboratories’ Q2FY25 consolidated net profit rises 47% to Rs 510 crore

Consolidated total income of the company increased by 22.51% at Rs 2,444 crore for Q2FY25

11:59 AM

12-AUG-2022

Divi’s Laboratories reports 26% rise in Q1 consolidated net profit

Total consolidated income of the company increased by 17.34% at Rs 2342.91 crore for Q1FY23

04:53 PM

12-FEB-2024

Divi’s Laboratories reports 17% rise in Q3 consolidated net profit

Consolidated total income of the company increased by 7.08% at Rs 1950 crore for Q3FY24

12:58 PM

14-AUG-2023

Divi’s Laboratories reports 49% fall in Q1 consolidated net profit

Total consolidated income of the company decreased by 20.66% at Rs 1859 crore for Q1FY24

02:30 PM

21-APR-2025

Divi’s Laboratories inks supply agreement with global pharmaceuticals firm

The company expects meaningful revenue contribution from this long-term agreement

11:59 AM

22-MAY-2023

Divi’s Laboratories reports 64% fall in Q4 consolidated net profit

Total consolidated income of the company decreased by 21.55% at Rs 2,016.92 crore for Q4FY23

12:44 PM

26-MAY-2025

Divi’s Laboratories inks pact with global pharma company

Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties

12:29 PM